Darling Ingredients Crescita futura

Future criteri di controllo 3/6

Darling Ingredients prevede che gli utili e i ricavi cresceranno rispettivamente di 29.9% e 3.1% all'anno. Si prevede che l'EPS crescerà di 30.9% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 13% in 3 anni.

Informazioni chiave

29.9%

Tasso di crescita degli utili

30.9%

Tasso di crescita dell'EPS

Food crescita degli utili	-1.3%
Tasso di crescita dei ricavi	3.1%
Rendimento futuro del capitale proprio	13.0%
Copertura analitica	Good
Ultimo aggiornamento	12 Nov 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Previsioni di crescita degli utili e dei ricavi

BMV:DAR * - Stime future degli analisti e dati finanziari passati (USD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	6,267	649	701	1,021	7
12/31/2025	6,087	489	564	990	10
12/31/2024	5,794	276	291	836	9
9/28/2024	5,912	261	468	902	N/A
6/29/2024	6,115	370	391	904	N/A
3/30/2024	6,417	543	437	975	N/A
12/30/2023	6,788	648	342	899	N/A
9/30/2023	6,942	720	340	858	N/A
7/1/2023	7,064	786	381	858	N/A
4/1/2023	6,957	735	416	850	N/A
12/31/2022	6,532	738	421	814	N/A
10/1/2022	6,074	737	551	891	N/A
7/2/2022	5,513	693	468	768	N/A
4/2/2022	5,061	687	433	718	N/A
1/1/2022	4,741	651	430	704	N/A
10/2/2021	4,451	540	319	606	N/A
7/3/2021	4,116	494	375	659	N/A
4/3/2021	3,766	363	449	729	N/A
1/2/2021	3,572	297	341	625	N/A
9/26/2020	3,412	495	267	570	N/A
6/27/2020	3,403	419	153	472	N/A
3/28/2020	3,382	380	7	349	N/A
12/28/2019	3,364	313	-1	363	N/A
9/28/2019	3,358	111	103	462	N/A
6/29/2019	3,328	79	67	425	N/A
3/30/2019	3,347	22	64	420	N/A
12/29/2018	3,388	101	73	399	N/A
9/29/2018	3,487	167	47	341	N/A
6/30/2018	3,611	180	N/A	341	N/A
3/31/2018	3,659	220	N/A	343	N/A
12/30/2017	3,662	128	N/A	410	N/A
9/30/2017	3,591	63	N/A	379	N/A
7/1/2017	3,508	84	N/A	420	N/A
4/1/2017	3,491	107	N/A	440	N/A
12/31/2016	3,392	102	N/A	391	N/A
10/1/2016	3,321	146	N/A	405	N/A
7/2/2016	3,320	108	N/A	402	N/A
4/2/2016	3,302	80	N/A	407	N/A
1/2/2016	3,391	79	N/A	421	N/A
10/3/2015	3,588	64	N/A	393	N/A
7/4/2015	3,713	87	N/A	422	N/A
4/4/2015	3,885	117	N/A	365	N/A
1/3/2015	3,956	64	N/A	275	N/A
9/27/2014	3,464	17	N/A	221	N/A
6/28/2014	2,911	30	N/A	123	N/A
3/29/2014	2,303	24	N/A	121	N/A
12/28/2013	1,802	109	N/A	211	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di DAR * ( 29.9% all'anno) è superiore al tasso di risparmio ( 8.1% ).

Guadagni vs Mercato: Si prevede che gli utili di DAR * ( 29.9% all'anno) cresceranno più rapidamente del mercato MX ( 11.7% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di DAR * cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di DAR * ( 3.1% all'anno) crescerà più lentamente rispetto al mercato MX ( 7.3% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di DAR * ( 3.1% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di DAR * sarà basso tra 3 anni ( 13 %).

Darling Ingredients Crescita futura

Future criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

Darling Ingredients Inc. to Report Q3, 2024 Results on Oct 24, 2024

Darling Ingredients Introduces Nextida GC

Insider recently bought Mex$966k worth of stock

Darling Ingredients Inc. Announces Retirement of Michael E. Rescoe from Its Board

Darling Ingredients Inc. to Report Q2, 2024 Results on Jul 25, 2024

Darling Ingredients Inc. to Report Q1, 2024 Results on Apr 25, 2024

Darling Ingredients Inc. Identifies Collagen Peptide Profiles for Targeted Health Benefits

Darling Ingredients Inc., Annual General Meeting, May 07, 2024

Darling Ingredients Inc. (NYSE:DAR) acquired Miropasz sp.z o.o.

Darling Ingredients Inc. to Report Q4, 2023 Results on Feb 27, 2024

Investor sentiment improves as stock rises 20%

Independent Director recently bought Mex$731k worth of stock

Third quarter 2023 earnings released: EPS: US$0.78 (vs US$1.19 in 3Q 2022)

Darling Ingredients Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investor sentiment deteriorates as stock falls 20%

Lead Independent Director recently bought Mex$1.7m worth of stock

Second quarter 2023 earnings released: EPS: US$1.58 (vs US$1.25 in 2Q 2022)

Second quarter 2023 earnings released: EPS: US$1.58 (vs US$1.25 in 2Q 2022)

Darling Ingredients Inc. to Report Q2, 2023 Results on Aug 08, 2023

Darling Ingredients Inc. Chief Strategy Officer John Bullock to Retire; Robert Day to Succeed Bullock

Darling Ingredients Inc.(NYSE:DAR) dropped from Russell Small Cap Comp Growth Index

Darling Ingredients Inc. Elects Kurt Stoffel to Board of Directors

Investor sentiment deteriorates as stock falls 18%

Darling Ingredients Inc. to Report Q4, 2022 Results on Feb 27, 2023

Darling Ingredients Inc. Announces Board Changes

Investor sentiment deteriorated over the past week

Darling Ingredients Inc. Announces Executive Changes

Darling Ingredients Inc. (NYSE:DAR) entered into definitive agreement to acquire Miropasz sp.z o.o. on November for approximately €110 million.

Darling Ingredients Inc. (NYSE:DAR) entered into definitive agreement to acquire Miropasz sp.z o.o. on November for approximately €110 million.

Darling Ingredients Inc. to Report Q3, 2022 Results on Nov 08, 2022

Darling Ingredients Inc. (NYSE:DAR) agreed to acquire Gelnex Indústria E Comércio Ltda. for approximately $1.2 billion.

Second quarter 2022 earnings released: EPS: US$1.25 (vs US$1.21 in 2Q 2021)

Darling Ingredients Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insider recently sold Mex$40m worth of stock

Executive VP & CFO recently sold Mex$39m worth of stock

Insider recently sold Mex$26m worth of stock

First quarter 2022 earnings released: EPS: US$1.17 (vs US$0.93 in 1Q 2021)

Darling Ingredients Inc. (NYSE:DAR) agreed to acquire FASA Group for approximately BRL 2800 million.

Darling Ingredients Inc. (NYSE:DAR) acquired Valley Proteins, Inc

Rousselot Biomedical Announces the World's First GelMA Produced Under GMP

Chairman & CEO recently sold Mex$76m worth of stock

Investor sentiment improved over the past week

Insider recently sold Mex$36m worth of stock

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Darling Ingredients Inc. to Report Fiscal Year 2021 Results on Feb 28, 2022

Darling Ingredients Inc. (NYSE:DAR) entered into an agreement to acquire Valley Proteins, Inc. for approximately $1.1 billion.

Darling Ingredients' Rousselot® Health Brand Obtains Patent from the European Patent Office for its SiMoGel™ Solution

Third quarter 2021 earnings released: EPS US$0.91 (vs US$0.62 in 3Q 2020)

Investor sentiment improved over the past week

Insider recently sold Mex$21m worth of stock

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita